Applications of miR-455-3p in diagnosis, treatment and prognosis of esophageal squamous cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUN YAT SEN UNIV CANCER CENT
- Publication Date
- 2015-07-15
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The invention is a biotechnology field, which involves a new application of Microrna and its Antagomir, which specializes in the application of MIR-455-3P and Antagomir-455-3P. Background technique
[0002] ESOPHAGEAL SQUAMOUS CARCINOMA (ESCC) is one of the most common malignant tumors in the world, with its mortality rate sixth.About 90%of my country's esophageal cancer is squamous cell carcinoma, and it has significant regionality. The incidence of esophageal squamous cell carcinoma in high incidence areas is 500 times that of low incidence areas.Factors such as the history of tobacco and alcohol, the lack of nutrition, the hot food, and the intake of carcinogen are all related to esophageal squamous cell carcinoma.Surgery and chemotherapy are important treatment methods for esophageal squamous cell carcinoma, but their 5 -year survival rate is only about 10%.Drug resistance is difficult to overcome the treatment of esophageal squamous cell carcinoma.Trad...